Collaborate Disseminate
A combination of immunotherapy and chemotherapy has shown promise for treating stage IV melanoma in a new clinical trial. The chemo drug targets a type of cell that suppresses the immune response, and together the two showed an increased response rate…. Continue reading Immunotherapy-boosting chemo drug shows promise in clinical trial
The first results from an advanced trial testing mRNA technology against cancer reveal 44% of patients fared better than those on conventional treatments alone. The preliminary announcement from Moderna reveals Phase 3 trials for its personalized mRNA … Continue reading Impressive results from “game-changing” mRNA skin cancer vaccine trial
New data from an ongoing Phase 1/2 clinical trial has revealed an experimental immunotherapy led to successful response rates in 73% of patients suffering from multiple myeloma, a deadly form of blood cancer. Based on this promising data, an applicatio… Continue reading New blood cancer therapy successful in three-quarters of trial patients
Immunotherapy is a promising cancer treatment, but getting it to work against solid tumors is proving difficult. A new study has not only identified a drug that’s effective against solid tumors, but may have uncovered a reason that immunotherapy often … Continue reading Promising prostate cancer drug hints at improved immunotherapy
An ounce of prevention is worth a pound of cure, so they say. Scientists have now demonstrated a new potential cancer vaccine that involves injections of dormant tumor cells to stimulate the immune system and help prevent the onset of cancer.Continue R… Continue reading Cancer vaccine using “zombie” cells shows promise in mouse tests
Researchers at Yale and the University of Rhode Island (URI) have demonstrated a new technique to fight cancer by attaching immunotherapy drugs to a molecule that seeks out the acidic environment of cancer cells. In tests in mice, a single dose was eno… Continue reading Homing missile molecule eradicates even advanced cancers in mice
Scientists have genetically modified a strain of the herpes virus to act as a cancer-killing agent in humans. Findings from an initial human trial are encouraging, with the experimental treatment proving safe and promisingly effective.Continue ReadingC… Continue reading Herpes virus genetically engineered to kill cancer
Scientists in Germany have reported that five patients undergoing an experimental treatment for lupus have all entered remission for up to 17 months. The promising breakthrough came from the use of CAR T cell immunotherapy, an emerging treatment for di… Continue reading Five lupus patients enter long-lasting remission after immunotherapy
Scientists at the University of California San Francisco (UCSF) have found a way to fight one of the most common cancer-causing mutations. The new drug puts up an “eat me” marker that can help the immune system or other drugs find and kill the cancer.C… Continue reading Immunotherapy combo targets mutation found in up to 25% of all cancers
The immune system is our first and most powerful line of defense, but during long-term battles the T cell foot-soldiers can become exhausted. Now, researchers have identified a specific molecule that helps certain T cells refresh themselves, which coul… Continue reading T-cell-refreshing molecule could be key to preventing immune exhaustion